Jamie B. Andreyka
Molecular Oncology (United States)(US)Seagen (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Peptidase Inhibition and Analysis, Genomics and Phylogenetic Studies, Neuroscience and Neuropharmacology Research
Most-Cited Works
- → Lysosomal Trafficking and Cysteine Protease Metabolism Confer Target-specific Cytotoxicity by Peptide-linked Anti-CD30-Auristatin Conjugates(2006)291 cited
- → Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment(2006)237 cited
- → Development and Properties of β-Glucuronide Linkers for Monoclonal Antibody−Drug Conjugates(2006)167 cited
- → Design, Synthesis, and in Vitro Evaluation of Dipeptide-Based Antibody Minor Groove Binder Conjugates(2005)90 cited
- → Dipeptide-based highly potent doxorubicin antibody conjugates(2005)85 cited
- → SGN-35, an Anti-CD30 Antibody-Drug Conjugate, Exhibits Potent Antitumor Activity for the Treatment of CD30+ Malignancies.(2005)16 cited
- → No-Wash Dyes for Calcium Flux Measurement(2003)11 cited
- → Cloning grills: High throughput cloning for structural genomics(2004)7 cited
- → Specific Tumor Targeting and Potent Bystander Killing with SGN-35, an Anti-CD30 Antibody Drug Conjugate.(2006)7 cited